Colocalization analysis identified shared causal variants between gene expression of NT5E, ALDH1A1, GCLC, GGH, GFPT1, CHIT1, ABCA7, ITGA7, and PD risk, supporting their potential as therapeutic targets. This evidence concerns the gene NT5E and Parkinson disease.